These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29478197)

  • 1. The use of high-throughput sequencing to investigate an outbreak of glycopeptide-resistant Enterococcus faecium with a novel quinupristin-dalfopristin resistance mechanism.
    Shaw TD; Fairley DJ; Schneiders T; Pathiraja M; Hill RLR; Werner G; Elborn JS; McMullan R
    Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):959-967. PubMed ID: 29478197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital.
    Werner G; Klare I; Spencker FB; Witte W
    J Antimicrob Chemother; 2003 Jul; 52(1):113-5. PubMed ID: 12805253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic of Enterococcus faecium clinical isolates with quinupristin/dalfopristin resistance in China.
    Wang S; Guo Y; Lv J; Qi X; Li D; Chen Z; Zhang X; Wang L; Yu F
    BMC Microbiol; 2016 Oct; 16(1):246. PubMed ID: 27769188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
    Abb J
    Int J Antimicrob Agents; 2007 Mar; 29(3):358-60. PubMed ID: 17229553
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.
    Bozdogan B; Leclercq R
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2720-5. PubMed ID: 10543753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First outbreak of colonization by linezolid- and glycopeptide-resistant Enterococcus faecium harbouring the cfr gene in a UK nephrology unit.
    Inkster T; Coia J; Meunier D; Doumith M; Martin K; Pike R; Imrie L; Kane H; Hay M; Wiuff C; Wilson J; Deighan C; Hopkins KL; Woodford N; Hill R
    J Hosp Infect; 2017 Dec; 97(4):397-402. PubMed ID: 28698020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada.
    Patel SN; Memari N; Shahinas D; Toye B; Jamieson FB; Farrell DJ
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):350-3. PubMed ID: 24095643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance mechanisms and clinical characteristics of linezolid-resistant Enterococcus faecium isolates: A single-centre study in South Korea.
    Cho SY; Kim HM; Chung DR; Kim SH; Huh HJ; Kang CI; Peck KR; Lee NY; Song JH
    J Glob Antimicrob Resist; 2018 Mar; 12():44-47. PubMed ID: 28941790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vancomycin-resistant enterococci: in vitro activity of quinupristin / dalfoprostin (RP 59500)].
    Betriu C; Valverde JF; Culebras E; Gómez M; Sánchez A; Palau ML; Picazo JJ
    Enferm Infecc Microbiol Clin; 1999; 17(7):335-9. PubMed ID: 10535185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of vancomycin-resistant Enterococcus faecium of the phenotype VanB in a hospital in Warsaw, Poland: probable transmission of the resistance determinants into an endemic vancomycin-susceptible strain.
    Kawalec M; Gniadkowski M; Zaleska M; Ozorowski T; Konopka L; Hryniewicz W
    J Clin Microbiol; 2001 May; 39(5):1781-7. PubMed ID: 11325990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Enterococcus faecium with macrolide resistance and reduced susceptibility to quinupristin/dalfopristin in a Japanese hospital: detection of extensive diversity in erm(B)-regulator regions.
    Isogai N; Urushibara N; Kawaguchiya M; Ghosh S; Suzaki K; Watanabe N; Quiñones D; Kobayashi N
    Microb Drug Resist; 2013 Aug; 19(4):298-307. PubMed ID: 23442208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large clonal outbreak of multidrug-resistant CC17 ST17 Enterococcus faecium containing Tn5382 in a Spanish hospital.
    Valdezate S; Labayru C; Navarro A; Mantecón MA; Ortega M; Coque TM; García M; Saéz-Nieto JA
    J Antimicrob Chemother; 2009 Jan; 63(1):17-20. PubMed ID: 19001448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre hospital outbreak in Sweden caused by introduction of a vanB2 transposon into a stably maintained pRUM-plasmid in an Enterococcus faecium ST192 clone.
    Sivertsen A; Billström H; Melefors Ö; Liljequist BO; Wisell KT; Ullberg M; Özenci V; Sundsfjord A; Hegstad K
    PLoS One; 2014; 9(8):e103274. PubMed ID: 25153894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the vanB phenotype.
    Kawalec M; Gniadkowski M; Kedzierska J; Skotnicki A; Fiett J; Hryniewicz W
    J Clin Microbiol; 2001 Dec; 39(12):4274-82. PubMed ID: 11724832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced susceptibility to quinupristin/dalfopristin in Enterococcus faecium in Greece without prior exposure to the agent.
    Karanika M; Prati A; Kiritsi M; Spiliopoulou I; Neonakis I; Anifantaki M; Petinaki E
    Int J Antimicrob Agents; 2008 Jan; 31(1):55-7. PubMed ID: 17923393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in vancomycin-resistant Enterococcus faecium causing outbreaks in Brazil.
    Palazzo IC; Pitondo-Silva A; Levy CE; da Costa Darini AL
    J Hosp Infect; 2011 Sep; 79(1):70-4. PubMed ID: 21741112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203.
    Johnson PD; Ballard SA; Grabsch EA; Stinear TP; Seemann T; Young HL; Grayson ML; Howden BP
    J Infect Dis; 2010 Oct; 202(8):1278-86. PubMed ID: 20812846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.
    Raad II; Hanna HA; Hachem RY; Dvorak T; Arbuckle RB; Chaiban G; Rice LB
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3583-5. PubMed ID: 15328133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
    Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
    Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity.
    Willems RJ; Bonten MJ
    Curr Opin Infect Dis; 2007 Aug; 20(4):384-90. PubMed ID: 17609597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.